What paperwork comes in the box, and what has to

The paper has its own rules

Most attention goes to the label stuck on the container. A different set of federal rules governs the printed information written for the patient rather than for a professional.

That material has a name and a definition. A Medication Guide is defined as approved patient labeling that conforms to the specifications set out in its own part of the regulations.

The word approved is doing the work in that sentence. A Medication Guide is not any leaflet a company chooses to print. It is a document the agency has approved before it may be distributed.

Understanding that one definition explains most of what follows, including why some boxes carry a Guide and others carry nothing that meets the description.

When one is required at all

The part sets out requirements for patient labeling for human prescription drug products, including biological products, that the agency determines pose a serious and significant public health concern requiring distribution of approved patient information.

It applies primarily to products used on an outpatient basis without direct supervision by a health professional. That is a description of nearly every product shipped to a home.

It also says, in one short sentence, that it applies to new prescriptions and to refill prescriptions. The duty is not a one-time welcome pack.

The requirement attaches where the agency determines in writing that patient labeling is necessary to safe and effective use.

Three circumstances can trigger that determination. Patient labeling could help prevent serious adverse effects. The product has serious risks relative to benefits that could affect a decision to use or continue it. Or, in the regulation's own words, the product is important to health and patient adherence to directions for use is crucial to the drug's effectiveness.

What one has to look like

The format rules are unusually concrete, which makes them easy to check against a piece of paper in your hand.

It has to be written in English, in nontechnical and understandable language, and it may not be promotional in tone or content.

It has to be scientifically accurate and based on the approved professional labeling, and it may not conflict with that labeling, although the wording need not be identical.

It has to be specific and comprehensive, legible and clearly presented. Type size is set at no smaller than ten points for every section except the manufacturer name and address and the revision date.

The words identifying it as a Medication Guide have to appear prominently at the top of the first page. A verbatim statement that the guide has been approved by the agency has to appear at the bottom.

Immediately below the title sit the brand name and the established or proper name, with the established name at no less than half the height of the brand name.

The headings, in the order the rule sets

The content is organized by required headings, and the rule lists them in a fixed order. The list itself is a reasonable checklist for any patient leaflet.

The brand name and the established or proper name come first, with a phonetic spelling of whichever name is used throughout.

Then a heading asking what the most important information to know about the product is, followed by a statement of the particular concern that created the need for the guide.

Then a heading asking what the product is, which identifies its indications and may not name an indication that is absent from the professional labeling.

Then headings covering who should not take it, how it should be taken, and what to avoid while taking it.

Then a heading covering possible or reasonably likely side effects, including serious or frequent adverse reactions and any risk of dependence.

The final block is general information. It carries a verbatim statement that medicines are sometimes prescribed for purposes other than those listed in a guide. It also carries the name and place of business of the manufacturer, packer or distributor. The revision date sits immediately after the last section.

Whose job it is to put it in your hands

The chain of responsibility is written out, and no link in it is optional.

The manufacturer has to obtain approval of the guide before it may be distributed at all.

A manufacturer shipping a container of such a product is responsible for ensuring guides are available. It does that by providing them in sufficient numbers to distributors, packers or authorized dispensers. Providing the means to produce them in sufficient numbers is the alternative.

A distributor or packer that receives them, or the means to produce them, has to pass them on to each authorized dispenser it ships a container to.

The authorized dispenser then has to provide the guide directly to each patient, or the patient's agent, when the product is dispensed.

And there is a requirement you can check yourself. The label of each container or package has to instruct the dispenser to provide a guide to each patient, and has to state how the guide is provided, prominently and conspicuously.

That last rule means the box is supposed to tell you whether a guide was owed. It is the cheapest check on this page.

Two ways the requirement bends, and the request that survives both

The part contains an exemptions section, and reading it is more useful than assuming the rule is absolute.

The agency may exempt or defer content or format requirements, on its own initiative or on a written request, where a requirement is inapplicable, unnecessary or contrary to patients' best interests.

Two requirements are carved out of that power. The rule against conflicting with the approved professional labeling cannot be waived, and neither can the identifying words at the top and the approval statement at the bottom.

The second bend is clinical. Where the prescribing practitioner determines it is not in a particular patient's best interest to receive a guide, the practitioner may direct that it not be provided.

That direction has a limit written into the same paragraph. The dispenser still has to provide a guide to any patient who requests information when the product is dispensed, regardless of the direction.

So asking is the move that works in every branch of the rule. A request at the point of dispensing overrides the one discretionary exception the part contains.

An older regime shows the pattern, and one clause is about vials

Medication Guides are not the only patient-labeling requirement. Two older rules cover specific product classes and they work the same way.

For oral contraceptives, each dispenser has to provide a patient package insert to each patient, and the insert is required to be placed in or to accompany each package dispensed. A product that does not comply is misbranded.

For estrogen products the rule is parallel, with the same misbranding consequence, and one clause speaks directly to injectables.

That clause covers bulk packages intended for multiple dispensing, and injectables in multiple-dose vials. A sufficient number of patient labeling pieces has to be included, so that one can go with each package or dose.

The bulk package itself has to carry instructions to the dispenser to include one piece with each package dispensed, or with each dose administered.

The pattern across all three regimes is the same. Patient labeling is imposed product class by product class, on a written agency determination, and never as a general background duty.

What the definition implies for a preparation with no approved labeling

One consequence follows from the definition rather than from any judgment about a product.

A Medication Guide is approved patient labeling. Where a preparation has no approved labeling behind it, there is nothing for that definition to attach to, and the part imposes nothing.

The same reasoning runs through the older rules, which are written for specific classes of approved products and reach nothing outside them.

That is a statement about the scope of three regulations. It is not a statement about the safety, quality or legality of anything, and it should not be read as one.

What it does mean practically is that any leaflet arriving with such a preparation is a document its preparer chose to write. Its accuracy, its currency and its completeness are that preparer's decisions rather than requirements of these parts.

A document written by choice can still be good. It is worth knowing which kind you are holding.

What to check in your own box

Whether the container or package label carries a statement instructing the dispenser to give you patient information, and says how it is provided.

Whether anything printed identifies itself as a Medication Guide at the top of its first page, and carries an approval statement at the bottom.

Whether a revision date appears immediately after the last section, so you can tell how old the document is.

Whether the leaflet names a manufacturer, packer or distributor and a place of business, or only the brand you bought from.

Whether the tone is informational or promotional, since a Medication Guide is expressly barred from being the latter.

And, at the moment of dispensing, whether asking for patient information produces a document. That request is the one route the rules keep open in every branch.

Sources

Each document below is named as it names itself, with the date printed on that document rather than the day it was read.

1. Title 21 Code of Federal Regulations Part 208, Medication Guides for Prescription Drug Products, read in full including sections 208.1, 208.3, 208.20, 208.24 and 208.26 — Electronic Code of Federal Regulations, Office of the Federal Register, January 2008
2. Title 21 Code of Federal Regulations Section 310.501, Patient package inserts for oral contraceptives — Electronic Code of Federal Regulations, Office of the Federal Register, March 2009
3. Title 21 Code of Federal Regulations Section 310.515, Patient package inserts for estrogens, including the clause on injectables in multiple-dose vials — Electronic Code of Federal Regulations, Office of the Federal Register, March 2009